IOVS AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1167/iovs.08-2536 on September 4, 2008
(Investigative Ophthalmology and Visual Science. 2009;50:263-272.)
© 2009 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.08-2536

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
iovs.08-2536v1
50/1/263    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sugita, S.
Right arrow Articles by Yamagami, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sugita, S.
Right arrow Articles by Yamagami, S.

Human Corneal Endothelial Cells Expressing Programmed Death-Ligand 1 (PD-L1) Suppress PD-1+ T Helper 1 Cells by a Contact-Dependent Mechanism

Sunao Sugita,*,1 Yoshihiko Usui,2 Shintaro Horie,1 Yuri Futagami,1 Yukiko Yamada,1 Juan Ma,2 Takeshi Kezuka,2 Hirofumi Hamada,3 Tomohiko Usui,4 Manabu Mochizuki,1 and Satoru Yamagami*,5,6

1From the Department of Ophthalmology & Visual Science, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan; the 2Department of Ophthalmology, Tokyo Medical University, Tokyo, Japan; the 3Department of Molecular Medicine, Sapporo Medical University, Sapporo, Japan; the 4Department of Ophthalmology, University of Tokyo Graduate School of Medicine, Tokyo, Japan; the 5Department of Ophthalmology, Tokyo Women’s Medical University Medical Center East, Tokyo, Japan; and the 6Corneal Regeneration Research Team, Foundation for Biomedical Research and Innovation, Kobe, Japan.

PURPOSE. This study was designed to determine whether human corneal endothelial (HCE) cells could regulate the activation of bystander T cells in vitro.

METHODS. HCE cell lines were established from primary HCE cells. Target-activated T cells were used allogeneic T cells and Jurkat T-cell lines. As an additional target, T-cell clones from uveitis patients were established from aqueous humor via a limiting dilution. T-cell activation was assessed for proliferation by [3H]-thymidine incorporation, carboxyfluorescein succinimidyl ester incorporation, or IFN{gamma} production. Expression of co-stimulatory molecules on IFN{gamma}-treated corneal endothelial and non-treated cells was evaluated by flow cytometry, RT-PCR, or immunohistochemistry. Expression of co-stimulatory receptors on target T cells was evaluated by flow cytometry. Blocking antibodies was used to abolish the HCE-inhibitory function.

RESULTS. HCE cells suppressed both in vitro proliferation and IFN{gamma} production by CD4+ T cells via a cell contact-dependent mechanism. HCE constitutively expressed co-stimulatory molecules programmed death-ligand 1 (PD-L1) and PD-L2, and their expression was enhanced by IFN{gamma}. HCE efficiently inhibited the proliferation of Th1 cells that overexpressed PD-1 among various activated T-cell lines and clones established from patients with uveitis or corneal endotheliitis. A neutralizing mAb for PD-L1, but not PD-L2, blocked the suppressive effect of HCE on Th1 cells.

CONCLUSIONS. HCE can impair the effector functions and activation of Th1 infiltrating CD4+ T cells via the PD-1/PD-L1 interaction. The data support the hypothesis that corneal endothelium may contribute to maintenance of the privileged immune status of the anterior chamber of the eye by inducing peripheral immune tolerance.





This article has been cited by other articles:


Home page
IOVSHome page
T. Hayashi, S. Yamagami, K. Tanaka, S. Yokoo, T. Usui, S. Amano, and N. Mizuki
Immunologic Mechanisms of Corneal Allografts Reconstituted from Cultured Allogeneic Endothelial Cells in an Immune-Privileged Site
Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3151 - 3158.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the Association for Research in Vision and Ophthalmology